Glucocorticoids/NNS
induced/VBD
down-regulation/NN
of/IN
glucocorticoid/NN
receptor/NN
mRNA/NN
expression/NN
in/IN
asthma/NN
./.

Although/IN
their/PRP$
precise/JJ
mechanism/NN
of/IN
action/NN
remains/VBZ
to/TO
be/VB
elucidated/VBN
,/,
glucocorticoids/NNS
represent/VBP
the/DT
most/RBS
effective/JJ
therapy/NN
in/IN
the/DT
treatment/NN
of/IN
asthma/NN
./.
=====
Interactions/NNS
between/IN
the/DT
glucocorticoid/NN
receptor/NN
and/CC
the/DT
AP-1/NN
complex/NN
have/VBP
been/VBN
shown/VBN
to/TO
regulate/VB
the/DT
transcription/NN
of/IN
some/DT
genes/NNS
,/,
including/VBG
glucocorticoid/NN
receptor/NN
itself/PRP
./.
=====
The/DT
aim/NN
of/IN
the/DT
present/JJ
study/NN
was/VBD
to/TO
compare/VB
the/DT
expression/NN
of/IN
mRNA/NN
for/IN
glucocorticoid/NN
receptor/NN
in/IN
human/JJ
blood/NN
monocytes/NNS
obtained/VBN
from/IN
seven/CD
unstable/JJ
untreated/JJ
asthmatic/JJ
patients/NNS
who/WP
were/VBD
subsequently/RB
treated/VBN
with/IN
high/JJ
doses/NNS
of/IN
parenteral/JJ
corticosteroid/NN
(/(
methyl/NN
prednisolone/NN
120/CD
mg/day/NN
)/)
for/IN
10/CD
days/NNS
./.
=====
mRNA/NN
expression/NN
was/VBD
identified/VBN
after/IN
RNA/NN
extraction/NN
using/VBG
RNAzol/NN
and/CC
analysed/VBN
after/IN
reverse/JJ
transcriptase/NN
,/,
by/IN
polymerase/NN
chain/NN
reaction/NN
using/VBG
a/DT
semiquantitative/JJ
competitive/JJ
hybridization/NN
assay/NN
./.
=====
All/DT
asthmatic/JJ
patients/NNS
showed/VBD
an/DT
improvement/NN
in/IN
their/PRP$
FEV1/NN
values/NNS
after/IN
corticosteroid/NN
treatment/NN
(/(
per/IN
cent/NN
of/IN
predicted/VBN
value/NN
68.28/CD
+/-/CC
4.93/CD
versus/CC
95.57/CD
+/-/CC
6.41/CD
,/,
P/NN
</JJR
0.02/CD
)/)
,/,
and/CC
a/DT
significant/JJ
decrease/NN
for/IN
glucocorticoid/NN
receptor/NN
mRNA/NN
expression/NN
(/(
P/NN
</JJR
0.02/CD
)/)
was/VBD
observed/VBN
in/IN
their/PRP$
monocytes/NNS
./.
=====
This/DT
is/VBZ
the/DT
first/JJ
report/NN
of/IN
an/DT
ex/FW
vivo/FW
down-regulation/NN
for/IN
the/DT
glucocorticoid/NN
receptor/NN
mRNA/NN
expression/NN
,/,
following/VBG
corticosteroid/NN
treatment/NN
./.